is indicated for the treatment of patients with metastatic colorectal cancer (mCRC) that is
resistant to or has progressed following an oxaliplatin-containing regimen.
VEGF-B=vascular endothelial growth factor B.
PlGF=placental growth factor.
ZALTRAP®, in combination with fluorouracil, leucovorin, irinotecan-(FOLFIRI), is indicated for the treatment of patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen.